The Research Program Sample Clauses

The Research Program. On the terms and conditions set forth in this Agreement, DNAP shall conduct research and development on approved Projects for ELM and shall consult with ELM regarding the application of biotechnology to products manufactured and distributed by ELM from time to time, including, without limitation, products of the agricultural seed industry. The Research Program shall have a ten-year (10) term, commencing with the date of this Agreement.
Sample 1Sample 2
AutoNDA by SimpleDocs
The Research Program. The Research Program shall be conducted for the Research Term. Subject to the other terms of this Agreement, the Research Term shall automatically be extended for an additional period of one (1) year unless, within [***] prior to the expiration of the Research Term, the JSC determines that additional Specific Targets should not be evaluated using the CAT Technology. The Research Term or any extensions thereof may also be extended upon mutual agreement of the Parties, which extension must be agreed upon at least ***] in advance of the end of the Research Term or the then current extension. At the first meeting of the JSC, on a regular basis thereafter, but in no event less than once every [***], and [***] after the end of the Research Term, the JSC shall [***]. Each list provided for by the proceeding shall be transmitted by reliable means to each member of the JSC who shall, at either the next meeting of the JSC or [***] after receipt thereof, confirm the accuracy of the content of each applicable list. No Specific Target on any list provided for under this Section 5.1.2 shall continue to be deemed a Specific Target under this Agreement if within [***] of designation by a Party such Party has not provided quantities of suitable materials sufficient to permit such Specific Target to be subjected to the CAT Technology.
Sample 1
The Research Program. Pursuant to the terms and conditions set forth in this Agreement, DNAP shall carry out Projects for SEMINIS. The Research Program shall have a ten (10) -year term, commencing with the date of this Agreement.
Sample 1
The Research Program. If Licensee agrees to the proposed substitution, the Parties will amend the definition of the Xxxx Laboratory (effective on a going-forward basis) to describe the group within Licensor that will be continuing the Research Program. If a substitute faculty member (or faculty members) acceptable to Licensee has not been agreed upon within [***] after Xxxxxx Xxxx, PhD or Xxxxx Xxxxxxxxx MD is no longer available to oversee and support the performance of the Research Program, or if the Parties have not agreed upon an amendment to the definition of the Xxxx Laboratory within that same time period, Licensee may transfer all outstanding Research Program SRAs to Licensee.
Sample 1
The Research Program. The Research Program shall be conducted for an initial term of *** (the “Initial Research Term”). The Research Term shall be extended for a period of *** if, during the Initial Research Term, the JSC determines that there exists an approach on which either Party has initiated Research, other than *** Approximately 5 lines omitted ***. The Initial Research Term may also be extended upon mutual agreement of the Parties, which extension shall be agreed upon at least four (4) months in advance of the end of the initial term or the then current extension. At the first JSC meeting following the end of each calendar year during the Research Term, and within thirty (30) days after the end of the Research Term, the JSC shall meet to prepare a list identifying all R&D Candidates and Products which were Researched or Developed during the calendar year or the Research Term, as applicable, and which remain subject to the terms and conditions of this Agreement, which lists shall be provided in writing to each Party.
Sample 1
The Research Program. FGN shall reimburse [*] or their designee(s) for .... - Article V - Patents Paragraph D before "their divisionals" insert "their parent applications." - Article XIII - Notices. Addresses are amended as follows: If to University:
Sample 1
The Research Program. The Material is provided to Recipient for the following use(s) only: (Specify what the material will be used for) and described in detail in the Protocol that is attached to and made part of this Agreement (the “Research Program”).
Sample 1
AutoNDA by SimpleDocs
The Research Program 
Sample 1Sample 2Sample 3See All (6)

Related to The Research Program

  • Research Program 2.1 University will use reasonable efforts to conduct the Research Program described in Attachment A which is hereby incorporated in full by reference (“Research Program”), and will furnish the facilities necessary to carry out said Research Program. The Research Program will be under the direction of _____________________ (“Principal Investigator”), or his or her successor as mutually agreed to by the Parties and will be con­ducted by the Principal Investigator at the University.

  • Research Program Term The Research Program shall be conducted during the period of five years commencing as of the Agreement Date ("Research Program Term"). Upon not later than seventy-five (75) days' prior written notice JT may, in its sole judgment, terminate the Research Program at the end of the third (3/rd/) year and fourth (4/th/) year of the Research Program. The RMC may terminate the Research Program any time during the Research Program Term if it unanimously determines the Research Program is no longer scientifically useful or that all potential Products would not be commercially viable. In case of such an early termination by JT or the RMC, JT shall be exempt from any payment(s) under Section 10(a) that would have become due and payable after the effective date of such early termination. Following any termination of the Research Program (i) that occurs simultaneously with the termination of this Agreement in accordance with Section 13 (i.e., no compound or Lead Compound has been designated previously a Collaboration Lead Compound in accordance with Section 3(b) and no Independent Lead Compound is being developed in accordance with Section 3(m)) or (ii) that is followed at some future date by the termination by JT of Development or co-promotion of any Collaboration Lead Compound and/or Product pursuant to Sections 3(l) or 5(c), respectively, or development of an Independent Lead Compound in accordance with Section 3(m) (A) any licenses granted by Tularik to JT will terminate, (B) JT will grant to Tularik an exclusive, sublicensable, worldwide license, to make, use and sell compounds, Collaboration Lead Compounds or Products under JT's interest in Program Patents and Program Know-How and (C) under the terms and conditions to be separately agreed, JT will also grant to Tularik a nonexclusive, sublicensable, worldwide license under any JT Patent Rights and Know-How to the extent necessary to practice the license granted under the Program Patents and Program Know-How in (B) (including, with respect to compounds, a limited number of JT's library compounds approved by JT); provided, however, that in the event the Research Program terminates but the Agreement has not terminated with respect to designated Collaboration Lead Compounds, Independent Lead Compounds and/or Products as provided in Section 2(g)(ii), Sections 2(g)(A), (B) and (C) shall apply only to those compounds, Collaboration Lead Compounds, Independent Lead Compounds and Products for which Development or co-promotion shall have been terminated and/or to those compounds or Lead Compounds that have not been designated previously a Collaboration Lead Compound in accordance with Section 3(b) or an Independent Lead Compound in accordance with Section 3(m); provided further that in the event that JT elects to pursue a Discontinued Compound or a Non-Proposed Compound on or before the first anniversary of the expiration or termination of the Research Program Term pursuant to Section 3(b)(iii) or 3(b)(iv), respectively, Sections 2(g)(A), (B) and (C) shall not apply to such Discontinued Compound or Non-Proposed Compound until such time as JT shall have terminated the Development or co-promotion of such Discontinued Compound or Non- Proposed Compound. Tularik will then be free to pursue clinical development and registration of such compounds, Lead Compounds and/or Products without obligation to JT except as provided in Section 4(f) or Section 5(c), as appropriate.

  • Development Program A. Development activities to be undertaken (Please break activities into subunits with the date of completion of major milestones)

  • Research Plan The Parties recognize that the Research Plan describes the collaborative research and development activities they will undertake and that interim research goals set forth in the Research Plan are good faith guidelines. Should events occur that require modification of these goals, then by mutual agreement the Parties can modify them through an amendment, according to Paragraph 13.6.

  • Research Program Funding 3.1.1 Pfizer will fund the research to be performed by Rigel, pursuant to the Agreement, according to the following schedule: COMMITMENT YEAR ANNUAL COMMITMENT 1 $2,350,000.00 2 $2,350,000.00 The funding payments of two million three hundred and fifty thousand dollars ($2,350,000.00) shall support the work of the equivalent of ten (10) full time employees ("FTEs") of Rigel.

  • Research Collaboration Upon FibroGen’s request, the Parties will discuss conducting a research program funded by AstraZeneca and directed toward franchise enhancement and lifecycle management for HIF Compounds or other topics that the Parties determine relevant to the Products and the Field. Upon agreement on the terms of such research program, the Parties will enter into a separate agreement or amend this Agreement accordingly.

  • Collaboration We believe joint effort toward common goals achieves trust and produces greater impact for L.A. County’s youngest children and their families.

  • Conduct of Research Program Each Party:

  • Research Term The Research Program will be carried out during the two (2) year period following the Effective Date, unless this Agreement is terminated in accordance with Article 13 (such period, as may be extended pursuant to this Section 3.2, being the “Research Term”). BMS shall have the option to extend the Research Term for three (3) additional one (1) year periods on a year-by-year basis after the initial two (2) year period. At least one hundred eighty (180) days prior to the scheduled expiration of the Research Term (i.e., the applicable anniversary of the Effective Date) BMS will provide Ambrx with a nonbinding, good faith indication of whether or not BMS intends to extend the Research Term. In order to exercise its option to extend the Research Term, BMS must provide Ambrx a written notice exercising BMS’ option to extend the Research Term at least ninety (90) days prior to the scheduled expiration of the Research Term (i.e., the applicable anniversary of the Effective Date). If BMS does not provide such written notice, the Research Term will end when scheduled (i.e., on the applicable anniversary of the Effective Date). For each extension of the Research Term, subject to Section 3.4, the JRC will prepare an update to the Research Plan which will include an updated Budget for the BMS-funded Ambrx FTEs to perform the work required under such Research Plan and the projected Third Party Costs.

  • Research Plans The Research Plan for the [***] Designated Target is attached as Schedule 2.2.3-1. Subsequent Research Plans agreed upon in accordance with Section 2.4.2.4 will be attached as additional sequentially numbered schedules (Schedule 2.2.3-2, Schedule 2.2.3-3, etc.).

Time is Money Join Law Insider Premium to draft better contracts faster.